Fortress Biotech, Inc.FBIONASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank60
3Y CAGR-18.6%
5Y CAGR+1.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-18.6%/yr
vs +15.3%/yr prior
5Y CAGR
+1.3%/yr
Recent deceleration
Acceleration
-33.9pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $133.96M | -9.0% |
| 2024 | $147.18M | -27.8% |
| 2023 | $203.96M | -17.9% |
| 2022 | $248.53M | +10.3% |
| 2021 | $225.25M | +79.8% |
| 2020 | $125.28M | -8.5% |
| 2019 | $136.92M | -2.7% |
| 2018 | $140.75M | +10.3% |
| 2017 | $127.59M | +80.1% |
| 2016 | $70.84M | - |